.through Dennis Crouch.The USPTO possesses 2 conventional features: (1) premium evaluation to ensure treatments fulfill the demanding statutory needs of patentability and (2) well-timed and also dependable processing of those applications. Recent records advises the Office is fighting with the second of these mandates, as shown in a vigorous uptick in Patent Term Change (PTA) awards. [Charts below]